iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAdell Harriman & Carpenter Inc
Latest Disclosed Ownership7,302 shares
Latest Disclosed Value $ 1,232,942
Adell Harriman & Carpenter Inc reports 0.52% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 4, 2026 - Adell Harriman & Carpenter Inc filed a 13F-HR form disclosing ownership of 7,302 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,232,942 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 7,340 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -0.52% during the quarter. The current value of the position is $956,927 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F iShares Biotechnology ETF Com 464287556 7,302 -38 -0.52 1,233 -0.48 0.0752
2026-02-06 2025-12-31 13F iShares Biotechnology ETF Com 464287556 7,340 -38 -0.52 1,239 16.24 0.0740
2025-11-04 2025-09-30 13F iShares Biotechnology ETF Com 464287556 7,378 -177 -2.34 1,065 11.52 0.0647
2025-08-04 2025-06-30 13F iShares Biotechnology ETF Com 464287556 7,555 -85 -1.11 956 -2.25 0.0634
2025-04-29 2025-03-31 13F iShares Biotechnology ETF Com 464287556 7,640 -209 -2.66 977 -5.79 0.0736
2025-01-30 2024-12-31 13F iShares Biotechnology ETF Com 464287556 7,849 -192 -2.39 1,038 -11.37 0.0722
2024-10-25 2024-09-30 13F iShares Biotechnology ETF Com 464287556 8,041 -157 -1.92 1,171 4.00 0.0851
2024-08-01 2024-06-30 13F iShares Biotechnology ETF Com 464287556 8,198 -1,718 -17.33 1,125 -17.28 0.0869
2024-04-25 2024-03-31 13F iShares Biotechnology ETF Com 464287556 9,916 -125 -1.24 1,361 -0.29 0.1120
2024-02-05 2023-12-31 13F iShares Biotechnology ETF Com 464287556 10,041 -926 -8.44 1,364 1.72 0.1262
2023-11-07 2023-09-30 13F iShares Biotechnology ETF Com 464287556 10,967 -230 -2.05 1,341 -5.50 0.1392
2023-08-04 2023-06-30 13F iShares Biotechnology ETF Com 464287556 11,197 -603 -5.11 1,420 -6.89 0.1443
2023-05-03 2023-03-31 13F iShares Biotechnology ETF Com 464287556 11,800 -1,378 -10.46 1,524 -11.91 0.1637
2023-02-03 2022-12-31 13F iShares Biotechnology ETF Com 464287556 13,178 -635 -4.60 1,730 7.12 0.1989
2022-11-03 2022-09-30 13F iShares Biotechnology ETF Com 464287556 13,813 -157 -1.12 1,616 -1.70 0.1966
2022-08-03 2022-06-30 13F iShares Nasdaq Biotechnology ETF Com 464287556 13,970 -775 -5.26 1,643 -14.47 0.2015
2022-04-29 2022-03-31 13F iShares Biotechnology ETF Com 464287556 14,745 -3,026 -17.03 1,921 -29.17 0.1868
2022-02-16 2021-12-31 13F iShares Nasdaq Biotechnology ETF Com 464287556 17,771 -402 -2.21 2,712 -7.69 0.2517
2021-11-05 2021-09-30 13F iShares Nasdaq Biotechnology ETF Com 464287556 18,173 -1,010 -5.27 2,938 -6.40 0.3059
2021-08-10 2021-06-30 13F iShares Nasdaq Biotechnology ETF Com 464287556 19,183 -1,271 -6.21 3,139 1.95 0.3304
2021-05-03 2021-03-31 13F iShares Nasdaq Biotechnology ETF Com 464287556 20,454 -785 -3.70 3,080 -4.29 0.3736
2021-02-05 2020-12-31 13F iShares Nasdaq Biotechnology ETF Com 464287556 21,239 -1,157 -5.17 3,218 6.10 0.4237
2020-11-06 2020-09-30 13F iShares Nasdaq Biotechnology ETF Com 464287556 22,396 -843 -3.63 3,033 -4.53 0.4526
2020-08-13 2020-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 23,239 -640 -2.68 3,177 23.48 0.5437
2020-05-07 2020-03-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 23,879 -2,517 -9.54 2,573 -19.14 0.5447
2020-02-07 2019-12-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 26,396 -650 -2.40 3,181 18.21 0.5232
2019-11-08 2019-09-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 27,046 -3,686 -11.99 2,691 -19.72 0.4874
2019-08-07 2019-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 30,732 -6,463 -17.38 3,353 -19.38 0.6263
2019-05-07 2019-03-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 37,195 -3,053 -7.59 4,158 7.14 0.8088
2019-02-08 2018-12-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 40,248 -4,158 -9.36 3,881 -28.32 0.8554
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 44,406 -527 -1.17 5,415 9.73 1.0131
2018-08-06 2018-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 44,933 -2,605 -5.48 4,935 -2.76 0.9779
2018-05-08 2018-03-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 47,538 2,869 6.42 5,074 6.40 1.0525
2018-02-05 2017-12-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 44,669 29,931 203.09 4,769 -2.99 1.0093
2017-11-06 2017-09-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 14,738 190 1.31 4,916 9.00 1.0741
2017-08-04 2017-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 14,548 3,253 28.80 4,511 36.17 1.0197
2017-05-01 2017-03-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY csus 464287556 11,295 -563 -4.75 3,313 5.28 0.7597
2017-02-03 2016-12-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY COM 464287556 11,858 2,258 23.52 3,147 13.25 0.7831
2016-11-04 2016-09-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 9,600 -49 -0.51 2,779 11.88 0.7039
2016-08-05 2016-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 9,649 -175 -1.78 2,483 -3.08 0.6485
2016-05-11 2016-03-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY COM 464287556 9,824 -2,325 -19.14 2,562 -37.66 0.6890
2016-02-12 2015-12-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 12,149 850 7.52 4,110 19.93 1.1038
2015-11-12 2015-09-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 11,299 67 0.60 3,427 -17.30 1.0064
2015-08-14 2015-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 11,232 -276 -2.40 4,144 4.86 1.0692
2015-05-11 2015-03-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 11,508 25 0.22 3,952 13.47 1.0404
2015-02-09 2014-12-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY COM 464287556 11,483 2,580 28.98 3,483 52.23 0.9492
2014-11-13 2014-09-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 8,903 0 0.00 2,288 0.00 0.6292
2014-08-11 2014-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 8,903 -575 -6.07 2,288 2.14 0.6292
2014-05-06 2014-03-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 9,478 -655 -6.46 2,241 -2.61 0.6615
2014-02-07 2013-12-31 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 10,133 -500 -4.70 2,301 3.23 0.7148
2013-11-05 2013-09-30 13F ISHARES NASDAQ BIOTECH Com 464287556 10,633 185 1.77 2,229 22.69 0.6272
2013-08-07 2013-06-30 13F ISHARES TR NASDAQ BIOTECHNOLOGY Com 464287556 10,448 10,448 1,817 0.6508
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.